Neil Fraser retired in July 2022 from his role as President of Medtronic Canada, a
subsidiary of Medtronic plc, a global leader in healthcare technology. He is currently
a board member of Sona Nanotech Inc. and a member of various health-related
councils including the CD Howe Institute and the International Working Group
on Global Research, Development & Innovation with the BRG Institute. In the
past, he has acted as Chair of Medtech Canada, Board Member of Baycrest Health
Sciences, Member of both the federal Advisory Panel on Healthcare Innovation
(the “Naylor report”) and the Ontario Health Innovation Council. Several of Neil’s
writings on the topic of healthcare innovation in Canada have been published,
and he has frequently been invited to share his expertise on value-based
procurement and outcomes-based healthcare innovation. In 2022, he was awarded
the Distinguished Leader Award by the Canadian College of Health Leaders.